E2025 / Eisai 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
E2025 / Eisai
NCT05726851: A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants

Completed
1
32
US
E2025, Placebo
Eisai Inc.
Healthy Volunteers
01/24
01/24

Download Options